TUC-S.R.L.
15.5.2024 11:34:35 CEST | Business Wire | Press release
Just over a month after the Digital World Premiere, TUC.tiny is ready to make its debut at VivaTech 2024, the most important technology fair in Europe. In Hall 1, Pavilion 41, TUC S.r.l. will present to the public for the first time its latest technological innovation: TUC.tiny®, the Modular Dashboard concept, and the TUC.technology offering, developed to revolutionize the world of mobility.
TUC.tiny® is the compact version of the industrialized technology launched last year, based on the TUC.technology® patent and released in over 140 countries. It is currently the subject of collaborations with industry leaders such as ZER01NE, the Hyundai Motor Group's Open Innovation Platform, for the development of "Human-centric" vehicles.
This technological gem is based on the three pillars of TUC: mechanical structure, electronic management, and data exchange. Thanks to the integration of USB Type-C technology, TUC.tiny® aims to reinvent the interaction between users and vehicles, converging mobility and everyday life.
The result of advanced research by TUC S.r.l. in technological miniaturization and simplification, TUC.tiny® represents the core of the company's patented technology, designed to innovate the value chain in the mobility sector with a "human-centric" approach. It is an ideal solution for both the main players in the sector and users, representing a perfect synthesis of their needs.
The Modular Dashboard, developed to showcase the potential of TUC.tiny®, is a true blank canvas, customizable infinite times thanks to TUC.tiny® and TUC.technology®. An environment to inhabit and configure without limits, adapting functionally and flexibly to the needs of users.
With TUC.tiny® and its advanced interface - including physical fastening, electrical connectivity, and data transfer - any device can be integrated into the modular dashboard design, making it immediately operational. TUC.tiny® supports all everyday devices with USB Type-C connection, distinguishing itself by seamlessly blending into any part of the vehicle. Its robustness is ensured by a mechanical or electro-actuated locking mechanism, introducing the novelty of NFC technology for added security.
The introduction of TUC.tiny® completes the TUC.technology® offering, marking a step forward towards the democratization of technology. The gateway to an advanced mobility experience becomes wider, easily accommodating the smart objects that animate our daily lives.
TUC.tiny® and TUC.technology® embody the vision of the mobility ecosystem of the future: interconnected, multimodal, circular, and dynamic. This technology not only connects but synthesizes different spheres of our lives, making mobility more accessible, customizable, and environmentally conscious.
TUC invites everyone to imagine and build together a world where technology unites us, improving every aspect of our daily journey. The project, which started in the automotive sector, now aims to scale the technology to new verticals such as aerospace and marine sectors.
“The World Premiere of TUC.tiny® at VivaTech 2024 is an important recognition for TUC.technology as an enabler of the Mobility of the Future," said Ludovico Campana, Inventor and CEO of TUC. “TUC.tiny® represents our promise for the future: the vision of a world where technology and mobility create personalized experiences designed around the needs of each individual. This is the future that TUC S.r.l. is building: a mobility ecosystem driven by the values of democratization, personalization, and sustainability."
TUC.tiny® and the Modular Dashboard are ready to be showcased live to the public at VivaTech 2024, demonstrating that this vision is already a reality.
For more information, visit the "NEWSROOM" section of the website: https://www.tuc.technology/newsroom.
ABOUT TUC.technology
TUC S.r.l. is a leading Deep-Tech company in mobility innovation, specializing in the development of modular solutions for vehicles that aim to simplify and revolutionize the concept of a vehicle. Distinguished by technological excellence on an international level, TUC has received significant recognitions, including exhibitions at CES in Las Vegas and the National Automobile Museum.
With the launch of TUC 3.0, the company sets new standards in the sector, collaborating with major global OEMs. Learn more at http://www.tuc.technology.
Facebook @TUCtechnology
Instagram @tuc.technology
Twitter @TUCtechnology
Linkedin @TUC.technology
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240515972855/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202629.8.2026 23:54:00 CEST | Press release
Qarmousha Pure Ultra White falcon sells for AED 1.5 million at the Abu Dhabi International Hunting and Equestrian Exhibition 2026 (ADIHEX) falcon auction Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom